Back
Acuity, Inc. 10K Form
Buy
67
AYI
Acuity, Inc.
Last Price:
$374.72
Seasonality Move:
5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-06-27 | 10Q | AYI/Acuity, Inc. Quarterly |
| 2024-04-03 | 10Q | AYI/Acuity, Inc. Quarterly |
| 2024-01-09 | 10Q | AYI/Acuity, Inc. Quarterly |
| 2023-10-26 | 10K | AYI/Acuity, Inc. Annual |
| 2023-06-29 | 10Q | AYI/Acuity, Inc. Quarterly |
| 2023-04-04 | 10Q | AYI/Acuity, Inc. Quarterly |
Receive AYI News And Ratings
See the #1 stock for the next 7 days that we like better than AYI
AYI Financial Statistics
Sales & Book Value
| Annual Sales: | $4.3B |
|---|---|
| Cash Flow: | $177.7M |
| Price / Cash Flow: | 21.94 |
| Annual Sales: | $88.76 |
| Price / Book: | 4.15 |
Profitability
| EPS (TTM): | 12.53290 |
|---|---|
| Net Income (TTM): | $396.6M |
| Gross Margin: | $2B |
| Return on Equity: | 15.65% |
| Return on Assets: | 9.15% |
Acuity, Inc. Earnings Forecast
Key Acuity, Inc. Financial Ratios
-
The Gross Profit Margin over the past 25 years for AYI is 46.07%.
-
The Selling, General & Administrative Expenses for AYI have been equal to 34.17% of Gross Profit Margin.
-
The Research & Development expenses have been 3.23% of Revenue.
-
The Interest Expense is 10.72% of Operating Income.
-
The Net Earning history of AYI is 9.13% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 16 years.
Acuity, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Electrical Equipment |
| Sector: | Industrials |
| Current Symbol: | AYI |
| CUSIP: | 00508Y |
| Website: | acuityinc.com |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 1.95 |
| Quick Ratio: | 1.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 29.48 |
|---|---|
| Forward P/E Ratio: | 16.93 |
AYI Technical Analysis vs Fundamental Analysis
Buy
67
Acuity, Inc. (AYI)
is a Buy
Is Acuity, Inc. a Buy or a Sell?
-
Acuity, Inc. stock is rated a BuyThe current Acuity, Inc. [AYI] share price is $369.51. The Score for AYI is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.